Filing Details

Accession Number:
0001209191-21-036686
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-28 19:36:51
Reporting Period:
2021-05-27
Accepted Time:
2021-05-28 19:36:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1796280 Oric Pharmaceuticals Inc. ORIC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1608936 Jacob Chacko C/O Oric Pharmaceuticals, Inc.
240 E. Grand Ave., 2Nd Floor
South San Francisco CA 94080
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-27 400 $25.07 22,732 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. Represents the weighted average share price of an aggregate total of 400 shares sold in the price range of $25.00 to $25.10 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.